ORYZON Announces FDA Clearance Of IND To Initiate A Collaborative Phase II Basket Study With Iadademstat In R/R Patients With Neuroendocrine Carcinomas (NECs)

Press/Media

Period	Nov 10 2022

Media coverage

Title	ORYZON Announces FDA Clearance Of IND To Initiate A Collaborative Phase II Basket Study With Iadademstat In R/R Patients With Neuroendocrine Carcinomas (NECs)
Media name/outlet	Drug Discovery Online
Country/Territory	United States
Date	11/10/22
URL	https://www.drugdiscoveryonline.com/doc/oryzon-announces-fda-clearance-of-ind-to-initiate-a-collaborative-neuroendocrine-carcinomas-necs-0001
Persons	Johnathan R. Whetstine, Neena Vijayvergia